The BCL-2 inhibitor venetoclax has an established role in the treatment of chronic lymphocytic leukemia (CLL), but its utilization in the community...READ MORE
clinical topic updates by Jennifer R. Brown, MD, PhD
Advances in the understanding of the pathobiology of chronic lymphocytic leukemia (CLL) have led to the success of targeted therapies such as Bruto...READ MORE
patient care perspectives by Michael C. Heinrich, MD
The risk of recurrence, growth, and spread of gastrointestinal stromal tumors (GIST) after surgery relates to key variables such as the size, locat......READ MORE
patient care perspectives by Carla M. Nester, MD, MSA, FASN
Novel treatment approaches are being sought for complement-mediated kidney diseases (CMKDs) such as complement 3 glomerulopathy (C3G). The pronounc...READ MORE
Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medic...READ MORE
